What is Fortis Healthcare Ltd's market cap?

Fortis Healthcare Ltd (FORTIS) has a market capitalization of ₹72,619 Cr.

What sector is FORTIS in?

Fortis Healthcare Ltd operates in the Healthcare — Hospitals & Diagnostics sector.

What is FORTIS's return on equity?

Fortis Healthcare Ltd has a return on equity (ROE) of 9.9%.

Loading company...

Analyzing...

The Organism · Company Intelligence

Fortis Healthcare Ltd

FORTIS|BSE: 532843

Healthcare — Hospitals & DiagnosticsHealthcare & Life Scienceswww.fortishealthcare.com

—

—|MCap ₹72,619 Cr

Promoter: 31.2%

Fortis Healthcare Ltd. engages in the provision of healthcare delivery services through its subsidiaries. The company is headquartered in Gurgaon, Haryana and currently employs 2,975 full-time employe

Secular Currents

Theme Connections

Healthcare Access

Intelligence Profile

TSF Score

54/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

26Clean

Trust Score

X-Ray

Concerns

🟠Below-average return on equity (9.9%)Business

Watch

Nothing flagged for monitoring

Strengths

🟢Good profitability (Net margin: 10.9%)Business
🟢Healthy revenue growth (11.0% CAGR 3yr)Business
🟢Low leverage (D/E: 0.33x)Business
🟢Consistent dividend payerOpportunity

The Numbers · Key Metrics

ROE

9.9%

Revenue Growth 3yr

11.0%

Debt/Equity

0.33x

₹72,480 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Hospitals & DiagnosticsProduct Sales ModelModel:Revenue = Number of Patients × Average Revenue per Patient (ARPOB for hospitals; Revenue per Test for diagnostics)

Key Insight

“Services business in Healthcare — Hospitals & Diagnostics.”

The Revenue Story

₹7,783 Cr service revenue.

Total Income₹7,850 Cr

Revenue₹7,783 Cr(99.1% of Total Income)

Other Income₹67 Cr(0.9% of Total Income)

The Cost Story

Employee costs at 15.0% of revenue — primary cost driver.

EBITDA₹3,418 Cr(40.9%)

Other Expenses₹3,197 Cr(38.3%)

Employee₹1,167 Cr(14.0%)

Depreciation₹386 Cr(4.6%)

Finance Costs₹184 Cr(2.2%)

0.2%EBITDA Margin

EBITDA

40.9%

Other Expenses

38.3%

Employee

14.0%

Depreciation

4.6%

Finance Costs

2.2%

Key Metrics

ROE

9.9%

vs median 7.9%

ROCE

11.8%

vs median 11.3%

Net Margin

10.9%

vs median 9.3%

EBITDA Margin

22.5%

vs median 21.9%

Debt To Equity

0.33x

vs median 0.16x

Rev Growth 3yr

11.0%

vs median 12.4%

EPS Growth 3yr

11.8%

vs median 11.8%

Employee Cost Ratio

15.00x

Forward View · Management Guidance

GUIDANCEQ2FY26High Impact

“we still maintain the full year addition of about 400, 500 beds?”

GUIDANCEQ2FY26High Impact

“Excluding one offs, an operating EBITDA margin stood at 24% in '25.”

GUIDANCEQ2FY26

“we are expecting around five, six percent ARPA growth, even in the second half.”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Hospitals & Diagnostics

KPI	Company	Sector Median
ROE	9.9%▲	7.9%
ROCE	11.8%▲	11.3%
Net Margin	10.9%▲	9.3%
EBITDA Margin	22.5%▲	21.9%
Debt To Equity	0.33x▲	0.16x
Rev Growth 3yr	11.0%▼	12.4%
EPS Growth 3yr	11.8%	11.8%
Employee Cost Ratio	15.00x	-

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Moderate Impact

7d+0.92→30d+0.92

Based on 1 article (0 in last 7 days)

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹8,770 Cr

PBT₹1,263 Cr

EPS₹12.72

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	₹8,770 Cr +12.7%	₹7,783 Cr +12.9%	₹6,893 Cr +9.5%	₹6,298 Cr +10.1%	₹5,718 Cr +41.9%	₹4,030 Cr -13.0%	₹4,632 Cr +3.6%	₹4,469 Cr
Other Income	₹66 Cr -1.3%	₹67 Cr +75.0%	₹38 Cr -38.0%	₹62 Cr +125.7%	₹27 Cr -41.3%	₹47 Cr -11.6%	₹53 Cr -43.0%	₹92 Cr
Total Income	₹8,836 Cr +12.6%	₹7,850 Cr +13.3%	₹6,931 Cr +9.0%	₹6,359 Cr +10.7%	₹5,745 Cr +40.9%	₹4,077 Cr -13.0%	₹4,685 Cr +2.7%	₹4,562 Cr
COGS	₹2,033 Cr +11.1%	₹1,830 Cr +13.1%	₹1,619 Cr +11.3%	₹1,455 Cr +7.2%	₹1,357 Cr +39.1%	₹976 Cr +1.3%	₹964 Cr +3.8%	₹928 Cr
	₹7,510 Cr +11.0%	₹6,765 Cr +10.9%	₹6,099 Cr +8.1%	₹5,641 Cr +10.7%	₹5,096 Cr +24.8%	₹4,082 Cr -9.7%	₹4,520 Cr -6.1%	₹4,814 Cr
Profit Before Tax	₹1,263 Cr +26.9%	₹996 Cr +17.3%	₹848 Cr +7.2%	₹792 Cr -17.8%	₹964 Cr ↑ Recovery	(₹4 Cr) ↓ Decline	₹227 Cr ↑ Recovery	(₹475 Cr)
Exceptional Items	(₹63 Cr) +29.1%	(₹89 Cr) ↓ Decline	₹16 Cr -78.2%	₹74 Cr -76.6%	₹315 Cr	₹1 Cr -98.0%	₹62 Cr ↑ Recovery	(₹222 Cr)
	₹297 Cr +50.3%	₹198 Cr -7.1%	₹213 Cr +17.7%	₹181 Cr -8.7%	₹198 Cr +98.9%	₹99 Cr -32.7%	₹148 Cr +30.2%	₹114 Cr
Net Profit	₹981 Cr +21.2%	₹809 Cr +25.4%	₹645 Cr +1.9%	₹633 Cr -19.9%	₹790 Cr ↑ Recovery	(₹56 Cr) ↓ Decline	₹91 Cr ↑ Recovery	(₹224 Cr)
Profit (Owners)	₹960 Cr +24.0%	₹774 Cr +29.3%	₹599 Cr +1.7%	₹589 Cr +6.1%	₹555 Cr ↑ Recovery	(₹110 Cr) ↓ Decline	₹58 Cr ↑ Recovery	(₹224 Cr)
Minority Interest	₹21 Cr -39.7%	₹35 Cr -24.1%	₹46 Cr +4.7%	₹44 Cr -81.2%	₹235 Cr +338.2%	₹54 Cr +59.7%	₹34 Cr	₹0.00 Cr
Other Comprehensive Income	₹7 Cr ↑ Recovery	(₹4 Cr) ↓ Decline	₹2 Cr ↑ Recovery	(₹8 Cr) +83.1%	(₹47 Cr) ↓ Decline	₹10 Cr	₹0.11 Cr ↑ Recovery	(₹45 Cr)
EPS	₹12.72	₹10.26	₹7.93	₹7.80	₹7.35	(₹1.45)	₹0.77	(₹2.96)
Diluted Shares	₹75 Cr	₹75 Cr	₹75 Cr	₹75 Cr	₹75 Cr	₹75 Cr	₹75 Cr	₹75 Cr
Profit Or Loss Of Associates	₹15 Cr +28.2%	₹12 Cr +21.1%	₹10 Cr -56.5%	₹22 Cr -9.6%	₹24 Cr -49.2%	₹48 Cr +291.1%	₹12 Cr -96.7%	₹364 Cr